Cleveland Biolabs is Biotechnology in United States that focus on Cleveland BioLabs Inc business. Founded in 2003. They cover business area such as Cleveland BioLabs Inc, novel approach, serious medical need, its proprietary platform, toll-like immune receptor activator, application, radiation injury, immuno-oncology, its lead product candidate, entolimod, an immuno-stimulatory agent, immunotherapy, Entolimod, a toll-like receptor, death, Acute Radiation Syndrome, (ARS, an oncology drug.
2003
( 21 years old in 2024 )
Cleveland BioLabs Inc
-
73 High Street
Buffalo, NY 14203
United States
Private
Cleveland BioLabs Incnovel approachserious medical needits proprietary platformtoll-like immune receptor activatorapplicationradiation injuryimmuno-oncologyits lead product candidateentolimodan immuno-stimulatory agentimmunotherapyEntolimoda toll-like receptordeathAcute Radiation Syndrome(ARSan oncology drug
* We use standard office opening hours in near Cleveland Biolabs's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cleveland Biolabs is Biotechnology business from United States that founded in 2003 (21 years old in 2024), Cleveland Biolabs business is focusing on Cleveland BioLabs Inc.
Cleveland Biolabs headquarter office and corporate office address is located in 73 High Street Buffalo, NY 14203 United States.
Cleveland Biolabs was founded in United States.
In 2024, Cleveland Biolabs is currently focus on Cleveland BioLabs Inc sector.
Above is snippet of Google Trends for "Cleveland BioLabs Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cleveland Biolabs, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
